location: Current position: Home >> Scientific Research >> Paper Publications

Structural Determinants of CX-4945 Derivatives as Protein Kinase CK2 Inhibitors: A Computational Study

Hits:

Indexed by:期刊论文

Date of Publication:2011-10-01

Journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Included Journals:Scopus、SCIE

Volume:12

Issue:10

Page Number:7004-7021

ISSN No.:1422-0067

Key Words:CK2 inhibitors; 3D-QSAR; molecular docking; molecular dynamics

Abstract:Protein kinase CK2, also known as casein kinase-2, is involved in a broad range of physiological events including cell growth, proliferation and suppression of apoptosis which are related to human cancers. A series of compounds were identified as CK2 inhibitors and their inhibitory activities varied depending on their structures. In order to explore the structure-activity correlation of CX-4945 derivatives as inhibitors of CK2, in the present study, a set of ligand- and receptor-based 3D-QSAR models were developed employing Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Index Analysis (CoMSIA). The optimum CoMFA (R-cv(2) = 0.618, R-pred(2) = 0.892) and CoMSIA (R-cv(2) = 0.681, R-pred(2) = 0.843) models exhibited reasonable statistical characteristics for CX-4945 derivatives. The results indicated that electrostatic effects contributed the most to both CoMFA and CoMSIA models. The combination of docking analysis and molecular dynamics (MD) simulation showed that Leu45, Lys68, Glu81, Val116, Asp175 and Trp176 of CK2 which formed several direct or water-bridged H-bonds with CX-4945 are crucial for CX-4945 derivatives recognition to CK2. These results can offer useful theoretical references for designing more potent CK2 inhibitors.

Pre One:Combined 3D-QSAR, Molecular Docking, and Molecular Dynamics Study on Piperazinyl-Glutamate-Pyridines/Pyrimidines as Potent P2Y(12) Antagonists for Inhibition of Platelet Aggregation (vol 51, pg 2560, 2011)

Next One:Combined 3D-QSAR, Molecular Docking, and Molecular Dynamics Study on Piperazinyl-Glutamate-Pyridines/Pyrimidines as Potent P2Y(12) Antagonists for Inhibition of Platelet Aggregation